Ishii K - Search Results

1

Minamimoto R, Ishii K, Kubota K, Morooka M, Okasaki M, Ito K, Mitsumoto T, Nakajima K, Sato T, Mochizuki M, Okazaki O. Minamimoto R, et al. Among authors: ishii k. Clin Nucl Med. 2012 Aug;37(8):807-9. doi: 10.1097/RLU.0b013e318251e1d3. Clin Nucl Med. 2012. PMID: 22785519

2

18F-FDG and 11C-methionine PET/CT findings in a case with anti-NMDA (NR2B) receptor encephalitis.

Morooka M, Kubota K, Minamimoto R, Furuhata M, Abe T, Ito K, Okasaki M, Ishii K, Ishiwata K. Morooka M, et al. Among authors: ishii k. Clin Nucl Med. 2012 Apr;37(4):400-2. doi: 10.1097/RLU.0b013e3182443c92. Clin Nucl Med. 2012. PMID: 22391718 No abstract available.

3

Re-evaluating the potentials and limitations of (99m)Tc-aprotinin scintigraphy for amyloid imaging.

Minamimoto R, Kubota K, Ishii K, Morooka M, Okasaki M, Miyata Y, Nakajima K, Sato T, Igari T, Hirai R, Okazaki O. Minamimoto R, et al. Among authors: ishii k. Am J Nucl Med Mol Imaging. 2013 Apr 9;3(3):261-71. Print 2013. Am J Nucl Med Mol Imaging. 2013. PMID: 23638337 Free PMC article.

4

Preclinical and clinical evaluation of O-[11C]methyl-L-tyrosine for tumor imaging by positron emission tomography.

Ishiwata K, Tsukada H, Kubota K, Nariai T, Harada N, Kawamura K, Kimura Y, Oda K, Iwata R, Ishii K. Ishiwata K, et al. Among authors: ishii k. Nucl Med Biol. 2005 Apr;32(3):253-62. doi: 10.1016/j.nucmedbio.2004.11.005. Nucl Med Biol. 2005. PMID: 15820760 Clinical Trial.

5

Whole-body distribution and brain tumor imaging with (11)C-4DST: a pilot study.

Toyohara J, Nariai T, Sakata M, Oda K, Ishii K, Kawabe T, Irie T, Saga T, Kubota K, Ishiwata K. Toyohara J, et al. Among authors: ishii k. J Nucl Med. 2011 Aug;52(8):1322-8. doi: 10.2967/jnumed.111.088435. Epub 2011 Jul 15. J Nucl Med. 2011. PMID: 21764794 Free article.

6

Initial human PET studies of metabotropic glutamate receptor type 1 ligand 11C-ITMM.

Toyohara J, Sakata M, Oda K, Ishii K, Ito K, Hiura M, Fujinaga M, Yamasaki T, Zhang MR, Ishiwata K. Toyohara J, et al. Among authors: ishii k. J Nucl Med. 2013 Aug;54(8):1302-7. doi: 10.2967/jnumed.113.119891. Epub 2013 Jun 26. J Nucl Med. 2013. PMID: 23804329 Free article. Clinical Trial.

7

Comparison of dosimetry between PET/CT and PET alone using (11)C-ITMM.

Ito K, Sakata M, Oda K, Wagatsuma K, Toyohara J, Ishibashi K, Ishii K, Ishiwata K. Ito K, et al. Among authors: ishii k. Australas Phys Eng Sci Med. 2016 Mar;39(1):177-86. doi: 10.1007/s13246-015-0419-5. Epub 2016 Jan 4. Australas Phys Eng Sci Med. 2016. PMID: 26728881 Clinical Trial.

8

Inter-rater variability of visual interpretation and comparison with quantitative evaluation of ¹¹C-PiB PET amyloid images of the Japanese Alzheimer's Disease Neuroimaging Initiative (J-ADNI) multicenter study.

Yamane T, Ishii K, Sakata M, Ikari Y, Nishio T, Ishii K, Kato T, Ito K, Senda M; J-ADNI Study Group. Yamane T, et al. Among authors: ishii k. Eur J Nucl Med Mol Imaging. 2017 May;44(5):850-857. doi: 10.1007/s00259-016-3591-2. Epub 2016 Dec 13. Eur J Nucl Med Mol Imaging. 2017. PMID: 27966045

9

Cortical blindness following aortic arch surgery.

Suzuki Y, Kiyosawa M, Mochizuki M, Ishii K, Senda M. Suzuki Y, et al. Among authors: ishii k. Jpn J Ophthalmol. 2001 Sep-Oct;45(5):547-9. doi: 10.1016/s0021-5155(01)00370-7. Jpn J Ophthalmol. 2001. PMID: 11583682

10

Automated semi-quantitative amyloid PET analysis technique without MR images for Alzheimer's disease.

Imabayashi E, Tamamura N, Yamaguchi Y, Kamitaka Y, Sakata M, Ishii K. Imabayashi E, et al. Among authors: ishii k. Ann Nucl Med. 2022 Oct;36(10):865-875. doi: 10.1007/s12149-022-01769-x. Epub 2022 Jul 11. Ann Nucl Med. 2022. PMID: 35821311 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,213 results

Search Page